Developing personalized therapies to enhance immune responses at mucosal surfaces
Multiscale considerations for immune engineering at mucosal interfaces
This study is looking at new ways to help your immune system work better at the surfaces of your body, like in your lungs and gut, by using special particles that send helpful signals to your immune cells, making it easier for your body to fight off germs and stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Delaware NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11138575 on NIH RePORTER |
What this research studies
This research focuses on creating personalized immunomodulatory therapies that target mucosal surfaces, which are critical barriers in the body such as those in the respiratory and gastrointestinal tracts. The approach involves using engineered particles to interact with immune cells at these mucosal interfaces, providing specific chemical signals to enhance immune responses. The goal is to overcome challenges in delivering these therapies effectively to the mucosal environment, which has unique properties that differ from other parts of the body. By addressing these challenges, the research aims to improve the body's ability to manage both beneficial and harmful microorganisms.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions affecting the respiratory or gastrointestinal tracts, or those with immune system disorders.
Not a fit: Patients with conditions unrelated to mucosal immunity or those who do not have access to the research facilities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for infections and immune-related conditions by enhancing the body's natural defenses at mucosal surfaces.
How similar studies have performed: While there has been significant progress in particle-based immune engineering, this specific focus on mucosal interfaces represents a novel approach that has not been extensively tested.
Where this research is happening
Newark, UNITED STATES
- University of Delaware — Newark, United States (Active)
Researchers
- Principal investigator: Fromen, Catherine a — University of Delaware
- Study coordinator: Fromen, Catherine a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.